PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Pushback on Rare Drug Prices: Not So Rare After All

The Changing Face of Interim Management

Big Data: Crunch Time for Pharma

Top Story
FDA Nominee Gottlieb to Face User Fees, De-Regulation Pressures
Trump's choice for FDA commissioner faces drug pricing, regulatory, and approval challenges., writes Jill Wechsler
/Read more/
Advertisement
E-Book: A High-Touch Approach to Product Access
Read it Today! Sponsored by AmerisourceBergen
Learn more
Regulatory
What First Amendment? FDA Remains Unfazed By Off-Label Communication Issues
An FDA Memo addressing First Amendment legal issues regarding off-label use of medical products falls short of the necessary clarity, write Jamie Kendall and Alexandra Schulz
/Read more/
Advertisement
Patient Centricity: Turning Rhetoric into Reality
Live Webinar: Thursday, March 30 at 10:30am EDT
Register now
Technology
Setting Sights on the Smart Supply Chain
Amid the push for a more intelligent and predictive supply chain, is it imperative for pharma companies to advance with their supply chain digitization strategies now—or is there still time to “wait and see?”
/Read more/
Advertisement
Biologics Manufacturing – Is Your Company Ready?
On Demand
Learn more
Biotech Roundtable
The Quest for Translation
Amid the hustle and bustle at the recent JP Morgan Healthcare Conference, Pharm Exec convened a roundtable discussion with CEOs from seven emerging biotechs to explore the prevailing issues and challenges facing the biopharmaceutical sector in 2017
/Read more/
Calendar
/ March 29–31, 2017: DIA EuroMeeting 2017 /
Glasgow, UK
/ April 26–28, 2017: CBI's 14th Annual Pharmaceutical Compliance Congress /
Washington, DC
/ May 11–12: PharmaMarketing Summit 2017 /
Grande Lakes, FL
/ May 21–24: 6th Pharmaceutical Sciences World Congress 2017 /
Stockholm, Sweden
/ June 6–7, 2017: Pharmaceutical Compliance Congress Canada /
Toronto, Canada
/ 20–22 June 2017: EphMRA Annual Conference 2017 /
Amsterdam, The Netherlands
 
Industry update
//Bristol-Myers Squibb appointed Dr. Thomas J. Lynch, Jr., as Executive Vice President and Chief Scientific Officer, effective March 16, 2017.//Tris Pharma (Monmouth Junction, NJ) appointed Paul Rogers as Chief Commercial Officer.//IDEA Pharma (New York, NY) appointed Geoff Birkett as Vice President, US Client Development.//Prothena Corporation (Dublin, Ireland) appointed Carol D. Karp as Chief Regulatory Officer.//
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com